REGENERON REPORTS SECOND QUARTER FINANCIAL AND OPERATING RESULTS BLA Filing for Auto-Inflammatory Diseases Planned for Early 2007 Two Antibody Candidates from VelocImmune Program to Enter Clinical Trials Each Year Beginning in 2007
Thursday, August 3, 2006 1 min read
Key Takeaway: REGENERON REPORTS SECOND QUARTER FINANCIAL AND OPERATING RESULTS BLA Filing for Auto-Inflammatory Diseases Planned for Early 2007 Two Antibody Candidates from VelocImmune Program to Enter Clinical Trials Each Year Beginning in 2007
Full Press Release Details
REGENERON REPORTS SECOND QUARTER FINANCIAL AND OPERATING RESULTS BLA Filing for Auto-Inflammatory Diseases Planned for Early 2007 Two Antibody Candidates from VelocImmune Program to Enter Clinical Trials Each Year Beginning in 2007.